Correlation Between Body Weight and Foot Progression Angle in Adolescents

Adolescent Development Clinical Trial

Official title:

Correlation Between Body Weight and Foot Progression Angle in Adolescents

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05095883
• Other study ID #: adolecents foot angles
• Status: Completed
• Start date: October 29, 2021
• Est. completion date: July 31, 2022

Study information

• Verified date: January 2024
• Source: Delta University for Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Obesity is associated with functional decline , altered spatiotemporal gait parameters (e.g. lower gait speed, shorter strides, and increased step width), and a significantly higher metabolic cost of walking compared to people with normal body weight. Obesity also negatively affects balance control.This study will investigate foot progression angle in adolescents related to their weight and category classification based on the CDC (Centers for Disease Control and Prevention) growth charts.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: July 31, 2022
• Est. primary completion date: July 27, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 13 Years to 18 Years

Eligibility

Inclusion Criteria:

• All children have normal stature for age percentile according to CDC chart.
• The sample will include both sex and will be divided in to 4 groups according to the CDC (Centers for Disease Control and Prevention) growth charts.
• All children are normal &perform all activities of daily living
• They were able to understand and follow verbal commands and instructions included in the testing procedures.

Exclusion criteria:

• All of them could be part of recreational activities in their public schools but no competitive sports. Children who participated in any regular sport activities involving the lower extremities will be excluded.
• None of them had any surgical intervention in the lower extremities.
• None of them had any history of musculoskeletal deformities or neuromuscular disorders.
• They had neither visual, auditory defect.

Related Conditions & MeSH terms

• Adolescent Development
• Body Weight
• Obesity, Adolescent
• Pediatric Obesity

Locations

Country	Name	City	State
Egypt	AAA	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Delta University for Science and Technology

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	foot progression angle for healthy group	participants in healthy group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait	assessed immediately after the procedure
Primary	foot progression angle for overweight group	participants in overweight group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait.	assessed immediately after the procedure
Primary	foot progression angle for obese group	participants in obese group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait.	assessed immediately after the procedure
Primary	foot progression angle for underweight group	participants in underweight group will be assessed for foot progression angle (FPA). The FPA is defined as the angle made by the long axis of the foot from the heel to 2nd metatarsal and the line of progression of gait.	assessed immediately after the procedure